Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

1.69
0.0000
Post-market: 1.690.00000.00%19:30 EDT
Volume:11.45K
Turnover:19.41K
Market Cap:28.61M
PE:-0.03
High:1.74
Open:1.68
Low:1.63
Close:1.69
52wk High:20.99
52wk Low:1.63
Shares:16.93M
Float Shares:2.15M
Volume Ratio:0.33
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-50.6904
EPS(LYR):-52.5900
ROE:-59.28%
ROA:-19.90%
PB:-1.03
PE(LYR):-0.03

Loading ...

Nov 30, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Major Issues Report

8-K - Current report
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2021

Major Issues Report

8-K - Current report
Sep 30, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2021

Major Issues Report

8-K - Current report